ASGCT 2024: Navigating the sea of gene and cell therapies

As the field of gene and cell therapy has grown and matured over the past decade, the American Society of Gene & Cell Therapy (ASGCT) Annual Meeting has also witnessed significant growth, and the 2024 Annual Meeting was no exception. Nearly 2000 abstracts were presented this year (1,983 total), representing a 12% increase over 2023. Each day was packed with sessions covering everything from AAV gene therapy to cancer immunotherapy to updates in the regulatory and manufacturing sectors. Recognizing the challenges posed by a growing number of scientific symposia, oral abstract presentations, and fireside chats, the Society introduced session paths for the first time to help attendees successfully navigate all of the content on display at the Annual Meeting. These paths included Cancer, Clinical Science, Gene Editing, Regulatory and Government Affairs, and Viral Vectors, in addition to First-Time Attendees.